Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05012397
Title Milademetan in Advanced/Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rain Oncology Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Medical Center Palo Alto California 94305 United States Details
Florida Cancer Specialists Fort Myers Florida 33901 United States Details
Florida Cancer Specialists Saint Petersburg Florida 33705 United States Details
Massachusetts General Hospital Boston Massachusetts 02214 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Hematology Oncology Associates of Central NY Syracuse New York 13057 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45267 United States Details
Sanford Health Sioux Falls South Dakota 57104 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Northwest Medical Specialities Tacoma Washington 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field